<DOC>
	<DOCNO>NCT00952068</DOCNO>
	<brief_summary>The primary objective study determine time onset analgesic effect Tramadol Contramid速 Once-A-Day ( OAD ) acute low back pain . Secondary objective include determine relationship analgesic effect plasma level Tramadol Contramid速 OAD examine safety single dose administration 200 mg Tramadol Contramid速 OAD .</brief_summary>
	<brief_title>A Pharmacodynamic/Pharmacokinetic Study Determine Onset Analgesic Effect Plasma Levels Tramadol Patients With Acute Low Back Pain Receiving Single 200 mg Dose Tramadol Contramid速 Once-a-Day</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Males female generally good health age 1880 year acute low back pain eligible study . Patients must pain moderate severe intensity patient rating pain intensity scale without analgesia . Oral write language comprehension level sufficient comply protocol complete studyrelated material . Must sign date REBapproved write Informed Consent form also sign dated Investigator prior study participation . Known history symptom suspicious : Spinal fracture Cancer ( i.e . constitutional symptom recent unexplained chill weight loss ) Spinal infection ( e.g . IV drug abuse , immunosuppression ) Cauda equina syndrome Spina bifida Foot drop Spinal surgery within 1 year study entry Body Mass Index ( BMI ) &gt; 37 Continuous chronic back pain More severe pain region lower back Treatment back pain nonpharmacological therapy ( e.g . acupuncture chiropractic adjustment , Transcutaneous Electrical Nerve Stimulation , physiotherapy etc . ) 3 week prior study entry Use sedative hypnotic , topical preparations/medications anaesthetic muscle relaxant within 5 halflives dose study medication Use analgesic within 6 hour dose study medication . In rare case , patient moderate severe pain despite take shortacting analgesic least 2 hour pass since dose shortacting analgesic , patient may enter . A major illness , require hospitalisation 3 month commencement screen period Unwillingness stop take pain medication study medication Previous failure treatment tramadol discontinuation treatment tramadol due adverse event Treatment within last 3 week follow medication : monoamine oxidase inhibitor ; tricyclic antidepressant tricyclic compound ( e.g . cyclobenzaprine , promethazine ) ; neuroleptic ; selective serotonin reuptake inhibitor ( SSRIs ) ; serotoninnorepinephrine reuptake inhibitor ( SNRIs ) drug reduces seizure threshold Treatment another investigational agent within last 30 day History seizure disorder Infantile Febrile Seizures Previous current opioid dependency Bowel disease cause malabsorption Pregnant lactate woman Known significant liver disease symptom significant liver disease Known significant renal disease symptom significant renal disease Current past substance abuse dependence , nicotine Allergy tramadol structurally similar drug ( e.g . opiate ) Any condition , opinion Investigators , would adversely affect patient 's ability complete study measure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Back Pain</keyword>
</DOC>